Past Meeting| Keystone Symposia

This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).

Web Desc
Inflammatory Diseases: Recent Advances in Basic and Translational Research and Therapeutic Treatments joint with Emerging Cytokine Networks Organizer(s): Chen Dong, Tadamitsu Kishimoto and Richard A. Flavell Date: January 17 - 22, 2014 Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada Sponsored by Biogen Idec, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen R&D: Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk A/S and Pfizer Inc. Summary of Meeting: Chronic inflammatory diseases represent a major threat to the health of our society. In the past several years, there have been advancements in understanding the immunological basis for inflammatory diseases and in identifying the cellular components and molecular pathways underlying their pathogenesis. Systems approaches have been taken in translational research of human patients. In addition, new biological and small molecule drugs have been tested with different degrees of success. The goal of this meeting is review these advances and to provide a single forum for basic, clinical and industrial experts to consider opportunities for further development of concepts, systems and therapeutics. This will be achieved by: 1) covering multiple types of inflammatory diseases that affect multiple organs; 2) gathering basic scientists, translational researchers and pharmaceutical investigators in the same setting; and 3) featuring roundtable discussion on future improvements in animal models and approaches to study human diseases and drug responses. We anticipate that this meeting will foster discussion on common pathways in inflammatory diseases, common methodology in studying human diseases and common challenges in designing the best medicine and clinical trials. Scholarship Deadline: October 8 2013 Discounted Abstract Deadline: October 8 2013 Abstract Deadline: October 30 2013 Discounted Registration Deadline: November 18 2013 Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting: We gratefully acknowledge additional support for this conference from: We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements: GlaxoSmithKline Novartis Institutes for BioMedical Research Novartis Pharma AG We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

Inflammatory Diseases: Recent Advances in Basic and Translational Research and Therapeutic Treatments

joint with Emerging Cytokine Networks

Organizer(s): Chen Dong, Tadamitsu Kishimoto and Richard A. Flavell

Date: January 17 - 22, 2014
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada

Sponsored by Biogen Idec, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen R&D: Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk A/S and Pfizer Inc.

Summary of Meeting:

Chronic inflammatory diseases represent a major threat to the health of our society. In the past several years, there have been advancements in understanding the immunological basis for inflammatory diseases and in identifying the cellular components and molecular pathways underlying their pathogenesis. Systems approaches have been taken in translational research of human patients. In addition, new biological and small molecule drugs have been tested with different degrees of success. The goal of this meeting is review these advances and to provide a single forum for basic, clinical and industrial experts to consider opportunities for further development of concepts, systems and therapeutics. This will be achieved by: 1) covering multiple types of inflammatory diseases that affect multiple organs; 2) gathering basic scientists, translational researchers and pharmaceutical investigators in the same setting; and 3) featuring roundtable discussion on future improvements in animal models and approaches to study human diseases and drug responses. We anticipate that this meeting will foster discussion on common pathways in inflammatory diseases, common methodology in studying human diseases and common challenges in designing the best medicine and clinical trials.

Scholarship Deadline: October 8 2013

Discounted Abstract Deadline: October 8 2013

Abstract Deadline: October 30 2013

Discounted Registration Deadline: November 18 2013

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

Boehringer Ingelheim Pharmaceuticals, Inc.

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

GlaxoSmithKline

Novartis Institutes for BioMedical Research

Novartis Pharma AG

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found